Key Laboratory of New Drugs Design and Discovery of Liaoning Province, Shenyang Pharmaceutical University, 103 Culture Road, Shenhe District, Shenyang 110016, China.
Eur J Med Chem. 2010 Jun;45(6):2663-70. doi: 10.1016/j.ejmech.2010.02.013. Epub 2010 Feb 10.
A number of 5-phenylisoxazole-3-carboxylic acid derivatives (5a-e, 11a-e) were synthesized and analyzed for their ability to inhibit xanthine oxidase. Most of the compounds exhibited potency levels in the micromolar/submicromolar range. The presence of a cyano group at the 3-position of phenyl moiety turned out to be the preferred substitution pattern, as its transformation into the nitro group determined a general reduction of the inhibitory potency. A molecular modeling study on compound 11a was performed to gain an insight into its binding mode with xanthine oxidase, and to provide the basis for further structure-guided design of new non-purine xanthine oxidase inhibitors related with 5-phenylisoxazole-3-carboxylic acid scaffold.
一些 5-苯并异恶唑-3-羧酸衍生物(5a-e,11a-e)被合成并分析其抑制黄嘌呤氧化酶的能力。大多数化合物表现出微摩尔/亚微摩尔范围内的效力水平。苯环部分的 3-位上存在氰基被证明是首选的取代模式,因为将其转化为硝基会导致抑制效力普遍降低。对化合物 11a 进行了分子建模研究,以深入了解其与黄嘌呤氧化酶的结合模式,并为进一步基于结构的设计与 5-苯并异恶唑-3-羧酸骨架相关的新型非嘌呤黄嘌呤氧化酶抑制剂提供基础。